A phase II trial of extended induction galiximab ([G] anti-CD80 monoclonal antibody) plus rituximab (R) in previously untreated follicular lymphoma (FL): Initial report of CALGB study 50402
- Citation:
- Ann Oncol vol 19 (suppl 4) abstr 143
- Meeting Instance:
- ICML 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 976
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. S. Czuczman J. L. Johnson S. Jung B. D. Cheson
- Networks:
- Study
- CALGB-50402
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: